Optimizing brief, focused symptom assessment in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): The FHNSI-10.

被引：1
|
作者：
Shaunfield, Sara
Yount, Susan
Boyken, Lara
Stoykova, Boyka
Agulnik, Mark
Samant, Sandeep
Cella, David
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Daiichi Sankyo UK Ltd, Gerrards Cross, London, England
[4] Univ Tennessee, Memphis, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e18743
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18743
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic significance of metastatic sites in recurrent or metastatic squamous cell carcinoma of the head and neck
    Nishimura, Ari
    Yokota, Tomoya
    Iida, Yoshiyuki
    Kamijo, Tomoyuki
    Mukaigawa, Takashi
    Onozawa, Yusuke
    Todaka, Akiko
    Hamauchi, Satoshi
    Kawakami, Takeshi
    Shirasu, Hiromichi
    Onoe, Tsuyoshi
    Ogawa, Hirohumi
    Kawabata, Takanori
    Yasui, Hirofumi
    Onitsuka, Tetsuro
    ANNALS OF ONCOLOGY, 2021, 32 : S296 - S296
  • [42] Recurrent head and neck squamous cell carcinoma
    Wu, S-Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Mark Agulnik
    Medical Oncology, 2012, 29 : 2481 - 2491
  • [44] Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Sacco, Assuntina G.
    Cohen, Ezra E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29) : 3305 - +
  • [45] DOXORUBICIN AND CISPLATIN FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    SANDLER, S
    BONOMI, P
    TAYLOR, B
    SHOWEL, J
    SLAYTON, R
    LERNER, H
    CANCER TREATMENT REPORTS, 1984, 68 (09): : 1163 - 1165
  • [46] Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Fushimi, Chihiro
    Baba, Daisuke
    Masubuchi, Tatsuo
    Yamazaki, Morio
    Kitani, Yosuke
    Kitajima, Tatsuya
    Tanaka, Junpei
    Hanyu, Kenji
    Tanaka, Naruhisa
    Miura, Kouki
    Tada, Yuichiro
    IN VIVO, 2020, 34 (05): : 2653 - 2657
  • [47] Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Thurnher, D
    Kornfehl, J
    Burian, M
    Gedlicka, C
    Selzer, E
    Quint, C
    Neuchrist, C
    Kornek, GV
    ANTI-CANCER DRUGS, 2001, 12 (03) : 205 - 208
  • [48] Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck
    Machiels, Jean-Pascal
    Schmitz, Sandra
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (03) : 359 - 371
  • [49] Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Borel, Christian
    Jung, Alain C.
    Burgy, Mickael
    CANCERS, 2020, 12 (09) : 1 - 19
  • [50] Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma
    Adamo, V
    Ferraro, G
    Pergolizzi, S
    Sergi, C
    Laudani, A
    Settineri, N
    Alafaci, E
    Scimone, A
    Spano, F
    Spitaleri, G
    ORAL ONCOLOGY, 2004, 40 (05) : 525 - 531
12345